By Nicholas G. Miller
$Aramark(ARMK-W)$ reported higher fourth-quarter sales and said it was onboarding an "unprecedented level of new business."
The company posted net income of $87.2 million, down from $122.3 million the year before. On a per-share basis, earnings were 33 cents a share, down from 46 cents a share the year prior.
Adjusted earnings were 57 cents a share. Analysts expected 64 cents, according to FactSet.
The company said its profit was dragged down by additional incentive-based compensation tied to its new contracts.
Sales rose 14% to $5.05 billion. Wall Street expected $5.16 billion.
The company guided for fiscal 2026 revenue of $19.55 billion to $19.95 billion and adjusted earnings of $2.18 to $2.28 a share. Analysts see 2026 adjusted earnings of $2.27 a share and revenue of $19.69 billion.
In October, the company was picked for a systemwide contract by Penn Medicine, which analysts said would support significant revenue growth beginning in fiscal 2026.
Aramark also increased its quarterly dividend by 14% to 12 cents a share.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
November 17, 2025 06:54 ET (11:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments